Rol actual de los nuevos antiplaquetarios en el síndrome coronario agudo

Ramon-Corbalan
Ramón Corbalan
2011-08-03

More articles by this author

Antiplatelet therapy advance in ACS and PCI

Jorge Belardi 2011-08-05

Protección gástrica en pacientes sometidos a angioplastia coronaria

Gastón Dussaillant 2011-08-03

Therapeutic strategies for the control of dyslipemia

Ada Cuevas 2011-08-03

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....